Knuff & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.15M | Sell |
8,555
-420
| -5% | -$90.4K | 0.55% | 39 |
|
|
2026
Q1 | $1.95M | Buy |
8,975
+1,400
| +18% | +$311K | 0.59% | 38 |
|
|
2025
Q4 | $1.73M | Sell |
7,575
-5
| -0.1% | -$1.14K | 0.51% | 38 |
|
|
2025
Q3 | $1.76M | Hold |
7,580
| – | – | 0.51% | 39 |
|
|
2025
Q2 | $1.41M | Sell |
7,580
-314
| -4% | -$58.4K | 0.44% | 39 |
|
|
2025
Q1 | $1.65M | Hold |
7,894
| – | – | 0.56% | 36 |
|
|
2024
Q4 | $1.4M | Buy |
7,894
+119
| +2% | +$21.9K | 0.43% | 44 |
|
|
2024
Q3 | $1.54M | Sell |
7,775
-100
| -1% | -$18.7K | 0.47% | 43 |
|
|
2024
Q2 | $1.35M | Sell |
7,875
-150
| -2% | -$24.8K | 0.44% | 47 |
|
|
2024
Q1 | $1.46M | Hold |
8,025
| – | – | 0.49% | 46 |
|
|
2023
Q4 | $1.24M | Hold |
8,025
| – | – | 0.45% | 48 |
|
|
2023
Q3 | $1.2M | Sell |
8,025
-150
| -2% | -$22K | 0.48% | 50 |
|
|
2023
Q2 | $1.1M | Sell |
8,175
-600
| -7% | -$88K | 0.41% | 51 |
|
|
2023
Q1 | $1.4M | Buy |
8,775
+5
| +0.1% | +$764 | 0.55% | 46 |
|
|
2022
Q4 | $1.42M | Sell |
8,770
-150
| -2% | -$23K | 0.6% | 42 |
|
|
2022
Q3 | $1.2M | Sell |
8,920
-675
| -7% | -$96.9K | 0.57% | 45 |
|
|
2022
Q2 | $1.47M | Hold |
9,595
| – | – | 0.66% | 42 |
|
|
2022
Q1 | $1.55M | Buy |
9,595
+268
| +3% | +$38.9K | 0.56% | 47 |
|
|
2021
Q4 | $1.26M | Sell |
9,327
-580
| -6% | -$68.5K | 0.39% | 56 |
|
|
2021
Q3 | $1.07M | Sell |
9,907
-15
| -0.2% | -$1.71K | 0.4% | 53 |
|
|
2021
Q2 | $1.12M | Hold |
9,922
| – | – | 0.42% | 55 |
|
|
2021
Q1 | $1.07M | Sell |
9,922
-25
| -0.3% | -$2.67K | 0.46% | 52 |
|
|
2020
Q4 | $1.07M | Buy |
9,947
+127
| +1% | +$12.2K | 0.44% | 53 |
|
|
2020
Q3 | $860K | Buy |
9,820
+340
| +4% | +$32K | 0.4% | 53 |
|
|
2020
Q2 | $931K | Buy |
9,480
+1,525
| +19% | +$134K | 0.51% | 48 |
|
|
2020
Q1 | $606K | Buy |
7,955
+490
| +7% | +$41.7K | 0.44% | 51 |
|
|
2019
Q4 | $661K | Hold |
7,465
| – | – | 0.4% | 50 |
|
|
2019
Q3 | $565K | Buy |
7,465
+190
| +3% | +$13K | 0.39% | 48 |
|
|
2019
Q2 | $529K | Buy |
7,275
+140
| +2% | +$11K | 0.38% | 51 |
|
|
2019
Q1 | $575K | Buy |
7,135
+400
| +6% | +$32.7K | 0.44% | 46 |
|
|
2018
Q4 | $621K | Buy |
+6,735
| New | +$592K | 0.61% | 36 |
|
Other funds holding ABBV
Knuff & Co's ABBV Position: Q2 2026 in Review
Knuff & Co reduced its AbbVie (ABBV) stake by 4.7% in Q2 2026, selling an estimated $90.4K and leaving 8,555 shares worth $2.15M. The position accounts for 0.55% of the portfolio, ranked #39.
Knuff & Co first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Knuff & Co held 8,555 shares of AbbVie worth $2.15M as of Q2 2026.
- Knuff & Co sold 420 AbbVie shares in Q2 2026, an estimated $90.4K.
- AbbVie made up 0.55% of Knuff & Co's portfolio in Q2 2026, its #39 holding.
- Knuff & Co first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Knuff & Co's 13F filing for Q2 2026, filed 10 Aug 2026.